GlassScriptPhysician profile
Joshua W Long
NPI 1922212729
$13,292.23
in general payments reported to CMS, 2019-2025
25 companies · $31.89 in 2025
The $31.89 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $303 · 2022: $187 · 2023: $299 · 2024: $12K · 2025: $31.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $3,137 · Food and Beverage: $1,157 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $3,136.89 |
| Food and Beverage | $1,157.05 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,167.33 | 2023-2025 | Da Vinci Surgical System |
| Medtronic, INC. | $309.89 | 2021-2024 | Signia, Minimed 780g |
| Novo Nordisk INC | $129.50 | 2021-2023 | Wegovy |
| Boston Scientific Corporation | $96.33 | 2024 | |
| Lilly USA, LLC | $71.12 | 2021-2024 | Jardiance, Zepbound |
| Cequr Corporation | $70.88 | 2024 | Cequr Simplicity |
| Amryt Pharma Holdings LTD | $54.54 | 2022-2023 | Mycapssa |
| Antares Pharma, INC. | $46.12 | 2024 | Xyosted |
| Purdue Pharma L.P. | $36.98 | 2024 | Nalmefene Hydrochloride |
| Teleflex LLC | $30.83 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Weck |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.56 | 2024 | Jardiance, Synjardy |
| Takeda Pharmaceuticals U.S.A., INC. | $25.78 | 2023 | Gattex |
| Bayer Healthcare Pharmaceuticals INC. | $23.96 | 2022 | |
| Insulet Corporation | $23.41 | 2022 | |
| Radius Health, INC. | $22.09 | 2023 | Tymlos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $18.18 | 2021 | |
| Amgen INC. | $18.15 | 2022 | |
| Standard Bariatrics, INC. | $17.08 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.96 | 2022 | |
| Conmed Corporation | $16.85 | 2023 | Airseal |
| Abbott Laboratories | $15.65 | 2025 | Eterna |
| Amneal Pharmaceuticals LLC | $15.53 | 2021 | |
| Ibsa Pharma INC. | $14.63 | 2022 | |
| Acerus Pharmaceuticals Corporation | $12.90 | 2022 | |
| Beta Bionics, INC. | $8.98 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.